PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.
This report by the Dutch Consulate Lagos Nigeria, in collaboration with PharmAccess, aims to build strong working partnerships, collaboration, and investments between Dutch Life-Science-Health businesses and the health market players in Nigeria.
The Nigerian health market is in urgent need of investments. A new market study launched by the Dutch consulate in Lagos and prepared by PharmAccess Nigeria identifies gaps in the health market and shows the most promising investments in terms of impact and financial return.
The Nigeria Health Sector Market Study Report is a follow-up to the market study conducted in 2015, by the Dutch Consulate in Lagos, Nigeria, in association with PharmAccess Nigeria. The study was commissioned based on a memorandum of Understanding (MOU) signed by the leadership of Nigeria and the Netherlands in 2018 and the outcome of an annual Trade and Investment Working Group (TIWG) meeting held in June 2021.
An overview of the landscape of the healthcare system in Nigeria from the supply side to demand side and key regulatory bodies is well captured in the report. The report also highlights gaps and prospects for viable private partnerships (PP), and public-private partnership (PPP) within the Nigerian health sector.
The aim of the study is to build strong working partnerships, collaboration, and investments between Dutch Life-Science-Health (LSH) businesses and the health market players in Nigeria in Government and the private sector.
The market information provided in the report, alongside identified opportunities can go a long way in triggering the inflow of investments that will improve the wellbeing of the Nigerian health market, and, by extension, the health of the Nigerian people.
Read the full report here.
